|
|
|
|
|
Detail |
| hsa-miR-7 |
|
Unspecified |
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-7 |
|
Unspecified |
microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. |
2007 |
|
|
|
|
|
|
| hsa-miR-7 |
|
Causal |
microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-7 |
|
Causal |
Repression of alpha-synuclein expression and toxicity by microRNA-7. |
2009 |
|
|
|
|
|
|
| hsa-miR-7 |
|
Unspecified |
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-7 |
|
Unspecified |
Heterogeneous dysregulation of microRNAs across the autism spectrum. |
2008 |
|
|
|
|
|
|
| hsa-miR-7 |
|
Causal |
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.
|
2008 |
|
|
|
|
|
|
| hsa-miR-7 |
|
Causal |
MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. |
2008 |
|
|
|
|
|
|
| hsa-miR-7 |
|
Unspecified |
MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222,miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. |
2009 |
|
|
|
|
|
|
| hsa-miR-7 |
|
Causal |
Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. |
2009 |
|
|
|
|
|
|
| hsa-miR-7 |
|
Causal |
Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. |
2009 |
|
|
|
|
|
|
| hsa-miR-7 |
|
Causal |
Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. |
2009 |
|
|
|
|
|
|